
Writer
Kirti Kumbhar
M. Pharm QA
Kirti Kumbhar is an M.Pharm graduate with experience in Quality Assurance at Lupin Limited and a strong interest in clinical research, regulatory affairs, and Trial Master File (TMF) management. She has developed knowledge of regulatory documentation, quality systems, compliance, and healthcare research through her professional experience. Passionate about clinical development and continuous learning, Kirti is committed to supporting high-quality healthcare documentation, regulatory excellence, and research-driven healthcare advancements.
109
Articles written or reviewed
About Kirti
Kirti Kumbhar (M. Pharm QA) is a writer at Pharmacally, with 109 published articles, each checked against primary sources by our editorial team.
On Pharmacally
Articles by Kirti Kumbhar
Clinical TrialsJazz Highlights New Xywav Data Showing Cardiometabolic Benefits and Personalized Dosing in Narcolepsy and Idiopathic Hypersomnia
Clinical TrialsOveporexton Improves Daily Functioning and Sleep in Narcolepsy Type 1
Clinical TrialsZilurgisertib Cuts New Bone Formation in FOP, FDA Grants Priority Review
New Drug ApprovalFDA Approves New KEYTRUDA-WELIREG Regimen to Prevent Kidney Cancer Recurrence
Clinical TrialsFDA Backs Phase 3 Plan as Enliven Posts Strong Phase 1 CML Results
New Drug ApprovalFDA Expands Organon’s TOFIDENCE Biosimilar Approval to CAR-T CRS and COVID-19
Clinical TrialsFDA Aligns on Phase 3 Design for Alterity’s ATH434 in MSA
Health TidingsUK Clears Moderna’s mRNA-4194 for Lynch Syndrome Cancer Prevention Study
Clinical TrialsSemaglutide Cuts Sleep Apnea Risk and Improves Cardiometabolic Health in New ADA 2026 AnalysesOur people
More from our experts
View our team

A. Musharaf Mohammad
Aabha Dey
Aasritha Thippavajjala